Dr Berni Sewell
Senior Lecturer
Public Health, Policy and Social Sciences
Telephone: (01792) 606504
Room: Office - 216
Second Floor
Vivian Building
Singleton Campus

Berni has been working in biomedical research since 2004 and started employment at Swansea University as a health economist in 2009. Since then she has been involved in over 20 projects as Principal Investigator or lead health economist with collaborators across the UK and Europe.

 Her main focus of work in recent years has been on cancer treatment, nosocomial infections, chronic pain and health technology assessment.

Recently completed work includes leading the health economic modelling undertaken to estimate the cost-effectiveness of stem cell transplantation and to inform guidance as recently published in NICE guidance NG52 (management of non-Hodgkin’s Lymphoma); lead health economist in modelling cost-effectiveness of new interventions in the treatment of chronic pain and lead health economist in the analysis of cost-effectiveness of a risk scoring tool in primary care.

Berni is the SCHE team leader for the health economic assessment of new medicines submitted to the All Wales Therapeutic and Toxicology Centre (AWTTC) as part of the review undertaken by the New Medicines Group and All Wales Medicines Strategy Group (AWMSG).

Areas of Expertise

  • health economics
  • cost-effectivness
  • economic modelling
  • health technology assessment

Publications

  1. et. al. Effects and costs of implementing predictive risk stratification in primary care: a randomised stepped wedge trial. BMJ Quality & Safety, bmjqs-2018-007976
  2. & Examining patterns in opioid prescribing for non-cancer-related pain in Wales: preliminary data from a retrospective cross-sectional study using large datasets. British Journal of Pain, 204946371880073
  3. et. al. Improving cancer symptom awareness and help-seeking among adults living in socioeconomically deprived communities in the UK using a facilitated health check: A protocol for the Awareness and Beliefs About Cancer (ABACus) Randomised Control Trial. BMC Public Health 19(1)
  4. et. al. Predictive risk stratification model: a randomised stepped-wedge trial in primary care (PRISMATIC). Health Services and Delivery Research 6(1), 1-164.
  5. et. al. Prehospital recognition and antibiotics for 999 patients with sepsis: protocol for a feasibility study. Pilot and Feasibility Studies 4(1)

See more...

Teaching

  • SHQM40 Social, Cultural and Economic Context of Health

    In this compulsory module students will develop a critical understanding and appreciation of the wider context of health care management. The social, cultural and economic context within which health and illness are defined and experienced and how these impact and influence the organisation and financing of health care and health systems will be critically explored.

Supervision

  • Trends in opioid prescribing and associated resource utilisation in Wales (TOPAS) (current)

    Student name:
    PhD
    Other supervisor: Prof Jaynie Rance
    Other supervisor: Dr Mari Jones
    Other supervisor: Dr Berni Sewell
    Other supervisor: Prof Ceri Phillips
  • An Economic Appraisal of the ‘Well-being through’ work staff health and well-being service provided for Abertawe Bro Morgannwg University Health Board (awarded 2018)

    Student name:
    PhD
    Other supervisor: Prof Ceri Phillips
    Other supervisor: Dr Berni Sewell
    Other supervisor: Prof Jaynie Rance